Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for Attention-Deficit Hyperactivity Disorder (ADHD) in children & adolescents with epilepsy: a randomized placebo-controlled trial.
Sylvain RheimsVania HerbillonSégolène GaillardCatherine MercierNathalie VilleuveFrédéric VillégaClaude CancesPierre CastelnauSilvia NapuriAnne de Saint-MartinStėphane AuvinSylvie N Guyen The TichPatrick BerquinJulitta de BellecizeMathieu MilhPascal RoyAlexis A ArzimanoglouJacques BodennecLaurent BezinBehrouz Kassainull nullPublished in: Epilepsia open (2024)
Our study remaining underpowered, no formal conclusion about the effect of Ps-Omega3 could be drawn. However, our data strongly suggested that the PS-Omega 3 formulation used in the current study did not improve ADHD symptoms in children with epilepsy.